GlassScriptPhysician profile
Lezlie Harris
NPI 1275865255
$2,877.36
in general payments reported to CMS, 2019-2025
17 companies · $49.81 in 2025
The $49.81 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.75 · 2022: $989 · 2023: $1,162 · 2024: $636 · 2025: $49.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,848.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,523.25 | 2022-2025 | |
| Pfizer INC. | $352.76 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $310.84 | 2022 | |
| Lundbeck LLC | $261.22 | 2022-2023 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $128.67 | 2022-2023 | Austedo Xr, Ajovy |
| Upsher-Smith Laboratories LLC | $74.44 | 2022-2023 | |
| Abbott Laboratories | $41.27 | 2021-2022 | |
| Dexcom, INC. | $37.04 | 2023-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $25.65 | 2022-2023 | Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $20.74 | 2025 | Breztri |
| Mylan Specialty L.P. | $19.06 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.81 | 2021 | |
| Vapotherm INC | $15.27 | 2022 | |
| Merck Sharp & Dohme LLC | $14.78 | 2024 | Gardasil 9, Gardasil |
| Astellas Pharma US INC | $14.51 | 2023 | Veozah |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $13.58 | 2022 | |
| Inogen, INC. | $8.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lezlie Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.